These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30278965)

  • 1. Extended neuromuscular blockade in acute respiratory distress syndrome does not increase mortality.
    Barmparas G; Dhillon NK; Tatum JM; Patel K; Thomsen GM; Mason R; Margulies DR; Ley EJ
    J Surg Res; 2018 Nov; 231():434-440. PubMed ID: 30278965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation.
    Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F
    Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blocking agents in ARDS.
    Slutsky AS
    N Engl J Med; 2010 Sep; 363(12):1176-80. PubMed ID: 20843254
    [No Abstract]   [Full Text] [Related]  

  • 11. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Aug; 63(2):344-50. PubMed ID: 17693834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial.
    Gerlach RM; Shahul S; Wroblewski KE; Cotter EKH; Perkins BW; Harrison JH; Ota T; Jeevanandam V; Chaney MA
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1673-1681. PubMed ID: 30655198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
    Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M;
    Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints. A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with Acute Respiratory Distress Syndrome.
    Sjoding MW; Schoenfeld DA; Brown SM; Hough CL; Yealy DM; Moss M; Angus DC; Iwashyna TJ;
    Ann Am Thorac Soc; 2017 Jan; 14(1):110-117. PubMed ID: 27788018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blockers and ARDS.
    Devlin JW; Garpestad E; Hill NS
    N Engl J Med; 2010 Dec; 363(26):2562; author reply 2563-4. PubMed ID: 21175322
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged weakness after cisatracurium infusion: a case report.
    Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
    Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisatracurium dosing in a patient with hyperthermia.
    Lim J; Cox J; Nguyen T; Arya R
    Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.